Free Newsletter
Register for our Free Newsletters
Newsletter
Zones
Advanced Composites
LeftNav
Aerospace
LeftNav
Amorphous Metal Structures
LeftNav
Analysis and Simulation
LeftNav
Asbestos and Substitutes
LeftNav
Associations, Research Organisations and Universities
LeftNav
Automation Equipment
LeftNav
Automotive
LeftNav
Biomaterials
LeftNav
Building Materials
LeftNav
Bulk Handling and Storage
LeftNav
CFCs and Substitutes
LeftNav
Company
LeftNav
Components
LeftNav
Consultancy
LeftNav
View All
Other Carouselweb publications
Carousel Web
Defense File
New Materials
Pro Health Zone
Pro Manufacturing Zone
Pro Security Zone
Web Lec
Pro Engineering Zone
 
 
 
News

Renowned Scientist to lead Tularemia research at Boston University Medical Center

Boston University : 25 February, 2005  (Technical Article)
Renowned research scientist Dr. John R. Murphy has been named the Principal Investigator of a grant from the National Institute of Allergy and Infectious Diseases to study tularemia, it was announced today by Boston University Medical Center officials. Dr. Murphy, a resident of the South End neighborhood in Boston, will be responsible for the administration of the tularemia grant over the next four years.
Renowned research scientist Dr. John R. Murphy has been named the Principal Investigator of a grant from the National Institute of Allergy and Infectious Diseases to study tularemia, it was announced today by Boston University Medical Center officials. Dr. Murphy, a resident of the South End neighborhood in Boston, will be responsible for the administration of the tularemia grant over the next four years.

The grant provides funding for research on development of a vaccine and better tests for early diagnosis of tularemia, also known as rabbit fever.

“Dr. Murphy’s exemplary track record in designing scientific experiments and his insistence on fostering and implementing a culture of biosafety in laboratory settings highly recommended him for this position,” said Dr. Thomas J. Moore, acting provost of BUMC. “We believe that Jack Murphy’s appointment will help BUMC maintain a position of leadership in this important research.”

Dr. Murphy brings stellar research credentials to this position. He has over 30 years of laboratory experience working on the molecular basis of pathogenesis, including field research in India and Bangladesh, as well as extensive experience working under Biosafety Levels 3 and 4 containment. He is currently a Professor of Medicine, Microbiology, a Research Professor of Biochemistry at the Boston University School of Medicine and a Professor of Biomedical Engineering in the College of Engineering at Boston University.

He was an associate professor in microbiology and molecular genetics at the Harvard Medical School from 1977-1983.

Dr. Murphy worked at the National Institutes of Health complex at Fort Detrick, Maryland, where his groundbreaking experiments with diphtheria toxins led to the development of the cancer-fighting drug Ontak, often prescribed for those patients suffering from leukemia and lymphoma.
Bookmark and Share
 
Home I Editor's Blog I News by Zone I News by Date I News by Category I Special Reports I Directory I Events I Advertise I Submit Your News I About Us I Guides
 
   Â© 2012 NewMaterials.com
Netgains Logo